We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Allergy Therapeutics Plc | LSE:AGY | London | Ordinary Share | GB00B02LCQ05 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.05 | -1.75% | 2.80 | 2.70 | 2.90 | 2.85 | 2.74 | 2.85 | 487,155 | 08:36:45 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 59.59M | -43.07M | -0.0090 | -3.11 | 133.46M |
TIDMAGY
RNS Number : 0732W
Allergy Therapeutics PLC
27 July 2018
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES (i) 1. Identity of the issuer or the Allergy Therapeutics PLC underlying issuer of existing shares to which voting rights are attached: (ii) 2 Reason for the notification (please tick the appropriate box or boxes): An acquisition or disposal of voting rights X An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments An event changing the breakdown of voting rights Other (please specify): --------------------------------------------------------------- 3. Full name of person(s) subject SOUTHERN FOX INVESTMENTS LTD. to the notification obligation: (iii) 4. Full name of shareholder(s) CHASE NOMINEES LTD -CMBLJPPB (if different from 3.): (iv) ------------------------------ 5. Date of the transaction and date 25(th) July, 2018 on which the threshold is crossed or reached: (v) ------------------------------ 6. Date on which issuer notified: 26(th) July , 2018 ------------------------------ 7. Threshold(s) that is/are crossed Over 22% or reached: (vi, vii) ------------------------------ 8. Notified details: A: Voting rights attached to shares (viii, ix) Class/type Situation previous Resulting situation after the triggering of to the triggering transaction shares transaction if possible using the ISIN CODE -------------------------- --------------------------------------------------------- Number Number Number Number of voting % of voting of of of shares rights rights (x) Shares Voting Rights ------------ ------------ ------------ ----------------------- ------------------ Direct Direct Indirect Direct Indirect (xi) (xii) ------------ ------------ ------------ ------------ --------- ------- --------- Ord GBP 0.01 GB00B02LCQ05 130,999,980 130,999,980 144,321,539 144,321,539 22% ------------ ------------ ------------ ------------ --------- ------- --------- B: Qualifying Financial Instruments Resulting situation after the triggering transaction Type of financial Expiration Exercise/ Number of voting % of voting instrument date (xiii) Conversion rights that rights Period (xiv) may be acquired if the instrument is exercised/ converted. ------------- -------------- ----------------------- ------------ C: Financial Instruments with similar economic effect to Qualifying Financial Instruments (xv, xvi) Resulting situation after the triggering transaction Type of financial Exercise Expiration Exercise/ Number of voting % of voting instrument price date Conversion rights instrument rights (xix, (xvii) period refers to xx) (xviii) --------- ----------- ------------ ------------------- ---------------- Nominal Delta --------- ----------- ------------ ------------------- -------- ------ Total (A+B+C) Number of voting rights Percentage of voting rights ---------------------------- 144,321,539 22% ---------------------------- 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: (xxi) Proxy Voting: 10. Name of the proxy holder: SOUTHERN FOX INVESTMENTS LTD -------------------------- 11. Number of voting rights proxy holder will cease to hold: -------------------------- 12. Date on which proxy holder will cease to hold voting rights: -------------------------- 13. Additional information: 14. Contact name: George O' Carroll ------------------- 15. Contact telephone number: +353-61-472019 -------------------
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
HOLUBUNRWRABUAR
(END) Dow Jones Newswires
July 27, 2018 12:26 ET (16:26 GMT)
1 Year Allergy Therapeutics Chart |
1 Month Allergy Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions